Published in Blood Weekly, February 10th, 2005
The grant will fund a 3-year stem cell bioprocessing project entitled "Therapeutic Products from Human Stem Cells." The aim of the project is to utilize the specific research, development and commercial expertise of the consortium members to develop and manufacture stem cell therapeutics for clinical and subsequent commercial application to address neurodegenerative diseases such as stroke, Huntington' disease and Parkinson disease.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.